hashimoto's semaglutide Does GLP-1 Help with Disease? Evidence and Safety GLP-1 with Hashimoto's Disease: Safety
Description
doi: 10.1056/NEJMoa2306963 65 KosiborodMNAbildstrmSZBorlaugBAButlerJChristensenLDaviesMet al
Ideal for individuals with a BMI of 30 or higher, or 27 and above with another weight-related condition, Wegovy has shown an average weight loss of 15% in clinical trials
But in the days and weeks following your last dose of Ozempic, youll likely experience an increased appetite as the drug leaves your body
This is where your healthcare provider gradually increases the dose until the desired effect is achieved without too many side effects
